PARP Inhibitor Market Scenario 2020-2028: - Latest Analysis
Author : akshay autade | Published On : 08 Oct 2021
Global Parp Inhibitor Market size was valued at USD 924 million in 2018 and is anticipated to grow at a CAGR of 27.4% during the forecast period. Cancer is the leading cause of death worldwide with 8.2 million cancer-related deaths in 2012 estimated by the World Health Organization (WHO). PARP Inhibitors are the medication that inhibits the enzyme known as poly ADP ribose polymerase (PARP). PARP inhibitors developed for treating many diseases, the most important one is cancer.
Key Factors Impacting the Growth of PARP Inhibitor Market:
· Increasing incidence of ovarian and breast cancer and a rising number of PARP inhibitor treatment therapies.
· By promising pipeline product that are showing positive leads to recent times and increasing awareness among aid professionals and patients
Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis: AstraZeneca Plc., Johnson & Johnson, GlaxoSmithKline plc., Pfizer, Inc., Clovis Oncology Inc., AbbVie Inc., Bristol - Myers Squibb, Merck KGaA, Genentech, Inc., Repare Therapeutics Inc., Sierra Oncology, Inc., Karyopharm Therapeutics Inc., Ono Pharmaceutical Co., LTD., and Jiangsu Hengrui Medicine Co., Ltd
According to the report, the PARP Inhibitor market report points out national and global business prospects and competitive conditions for PARP Inhibitor. Market size estimation and forecasts were given based on a detailed research methodology tailored to the conditions of the demand for PARP Inhibitor. The PARP Inhibitor market has been segmented as By Drug (Lynparza, Niraparib, Rucapairb, Talazoparib, Veliparb), Indication (Overian Cancer, Breast Cancer, Prostate Cancer, Pancreatic Cancer), Distribution Channel (Hospitals, Retail Pharmacies, Online Channels) . Historical background for the demand of PARP Inhibitor has been studied according to organic and inorganic innovations in order to provide accurate estimates of the market size. Primary factors influencing the growth of the demand PARP Inhibitor have also been established with potential gravity.
Regional segmentation and analysis to understand growth patterns: The market has been segmented in major regions to understand the global development and demand patterns of this market. By region, the PARP Inhibitor market has been segmented in North America, Europe, Asia Pacific, Middle East & Africa, and South America. The North America and Western Europe regions are estimated to register a stable demand during the forecast period with market recovery from recent slowdowns.
North America region includes the US, Canada, and Mexico. The US is estimated to dominate this market with a sizeable share followed by Canada, and Mexico. The industrial sector is a major contributor to the US and Canada economies overall. Hence, the supply of advanced materials in production activities is critical to the overall growth of industries in this region.
This report provides:
1) An overview of the global market for PARP Inhibitor market and related technologies.
2) Analysis of global market trends, yearly estimates, and annual growth rate projections for compounds (CAGRs).
3) Identification of new market opportunities and targeted consumer marketing strategies for the global PARP Inhibitor market.
4) Analysis of R&D and demand for new technologies and new applications
5) Extensive company profiles of key players in the industry.
The researchers have studied the market in-depth and have developed important segments such as product type, application, and region. Each and every segment and its sub-segments are analyzed based on their market share, growth prospects, and CAGR. Each market segment offers in-depth, both qualitative and quantitative information on market outlook.
QMI has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the world’s most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.
Quince Market Insights
Office No- A109
Pune, Maharashtra 411028
Phone: APAC +91 706 672 4848 / US +1 208 405 2835 / UK +44 1444 39 0986